Published in Oncol Lett on August 14, 2015
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science (1992) 16.38
Array comparative genomic hybridization and its applications in cancer. Nat Genet (2005) 6.69
Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc Natl Acad Sci U S A (1994) 5.74
The emerging landscape of breast cancer susceptibility. Nat Genet (2008) 4.27
Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev (2005) 3.40
The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. Stem Cells (1998) 3.13
Detection of complete and partial chromosome gains and losses by comparative genomic in situ hybridization. Hum Genet (1993) 2.64
Prognostic relevance of gene amplifications and coamplifications in breast cancer. Cancer Res (2004) 2.55
Genome screening by comparative genomic hybridization. Trends Genet (1997) 2.23
Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res (1997) 2.14
Quantitative analysis of comparative genomic hybridization. Cytometry (1995) 1.72
Genetic alterations in primary breast cancers and their metastases: direct comparison using modified comparative genomic hybridization. Genes Chromosomes Cancer (1997) 1.63
Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet (2004) 1.61
Comparative genomic hybridization reveals complex genetic changes in primary breast cancer tumors and their cell lines. Cancer Genet Cytogenet (2000) 1.59
Comparative genomic hybridisation. Mol Pathol (1999) 1.56
Patterns of chromosomal imbalances in invasive breast cancer. Int J Cancer (2000) 1.38
Tumor biology of infiltrating lobular carcinoma. Implications for management. Ann Surg (1995) 1.35
Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease. Genes Chromosomes Cancer (2007) 1.34
Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer (1997) 1.34
Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer. Eur J Cancer (2012) 0.95
An array CGH based genomic instability index (G2I) is predictive of clinical outcome in breast cancer and reveals a subset of tumors without lymph node involvement but with poor prognosis. BMC Med Genomics (2012) 0.83
Mosaic Turner syndrome: cytogenetics versus FISH. Ann Hum Genet (1999) 0.83
Genetic imbalances in pT2 breast cancers of southern Chinese women. Cancer Genet Cytogenet (2001) 0.82
Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression. J Exp Clin Cancer Res (1999) 0.82
Cytogenetic studies of esophageal squamous cell carcinomas in the northern Chinese population by comparative genomic hybridization. Cancer Genet Cytogenet (2002) 0.81
Chromosomal aberrations as detected by array comparative genomic hybridization in early low-grade intraepithelial neoplasias of the breast. Histopathology (2011) 0.80
Covariation of copy number located at 16q22.1: new evidence in mammary ductal carcinoma. Oncol Rep (2012) 0.79
Genomic and phenotypic profiles of two Brazilian breast cancer cell lines derived from primary human tumors. Oncol Rep (2013) 0.79
17p12 deletion in breast cancer predicts resistance to neoadjuvant chemotherapy. Exp Ther Med (2011) 0.79
Characterization of genomic alterations in radiation-associated breast cancer among childhood cancer survivors, using comparative genomic hybridization (CGH) arrays. PLoS One (2015) 0.78